The research meticulously analyzed 47 specific medical services shown by rigorous clinical studies to offer minimal or no benefit to most patients. These services, often routine or preventive in nature, have increasingly come under scrutiny as healthcare costs continue to skyrocket. The core argument of the study centers on the need to carefully differentiate which patients genuinely benefit from certain medical interventions and which do not, thereby enabling targeted reductions in unnecessary care. Such a data-driven approach could free up Medicare resources for higher-value care, ensuring more effective allocation of limited funds.

Significantly, the study highlighted that just five particular services account for an estimated $2.6 billion of the total $4.4 billion in potentially avoidable spending. These five services have all been assigned a “D” grade by the U.S. Preventive Services Task Force (USPSTF), indicating that high-quality evidence shows either ineffectiveness or that the potential harms of these interventions outweigh any benefits. This grading is crucial as it empowers the Secretary of Health and Human Services with the regulatory authority, under the Affordable Care Act, to withhold Medicare payments for these services—a powerful policy lever for curbing low-value care.

Among the five targeted interventions are screenings that may seem routine but are problematic in older adults without symptoms or risk factors. These include blanket screening for chronic obstructive pulmonary disease (COPD), bacteria screening in asymptomatic patients’ urine, prostate-specific antigen (PSA) testing in men over 70 absent a relevant history, screening for carotid artery blockages, and electrocardiogram (ECG) screenings for heart rhythm irregularities in symptom-free older adults. The study emphasizes that eliminating the use of these particular screenings in unlikely-to-benefit populations could markedly reduce unnecessary expenditures while avoiding potential iatrogenic harms.

Beyond these primary five, the researchers also cataloged 42 additional services deemed low-value for at least some patient groups. These were identified through comprehensive evaluations by major medical professional societies and other bodies, relying on extensive clinical research. Notably, seventeen of these additional services, combined with three from the USPSTF “D” grade list, collectively represent over 94% of the low-value medical procedures detected in the analysis, illuminating specific focal points for healthcare cost reduction.

The lead authors, health economist Dr. David D. Kim from the University of Chicago and primary care physician Dr. A. Mark Fendrick from the University of Michigan’s Center for Value-Based Insurance Design, undertook this study in response to national priorities aimed at mitigating waste and controlling Medicare’s burgeoning costs. Their analysis utilized anonymized data sourced from a randomized sample of traditional Medicare claims spanning 2018 to 2020, projecting these findings across the entire Medicare population. This robust data-driven methodology strengthens the study’s relevance and reliability in informing future policy decisions.

Dr. Kim underscored the importance of a nuanced approach to reducing low-value care. He noted that while patients who stand to benefit should always have access to necessary procedures, indiscriminate use leads to substantial wasted spending and increased risk exposures. Moreover, the study’s financial estimates do not encompass downstream spending triggered by these low-value interventions, which can be much higher. For example, universal PSA screening has been reported to incur up to six dollars in additional subsequent care for every dollar spent on screening itself, magnifying the economic burden.

Dr. Fendrick pointed out the study’s grounding in clinical evidence distinguishes it from more simplistic cost-cutting measures that might compromise patient outcomes. This patient-centered analysis respects the heterogeneity of clinical scenarios, permitting a more tailored suppression of services unlikely to produce meaningful health improvements. The approach aligns with principles of value-based insurance design, actively encouraged within the framework of the Affordable Care Act, which empowers Medicare to exclude coverage for certain low-value preventive services based on USPSTF grades.

This work has significant policy relevance as it advances beyond blunt expenditure reductions towards smarter, evidence-based healthcare reform. By deploying clinical criteria to guide payment policies, Medicare can potentially achieve savings without jeopardizing care quality—balancing economic sustainability with patient safety. The ability to target reductions specifically to services and patient populations with measurable low value represents a critical evolution in health policy strategy.

The study’s comprehensive list of 47 services, alongside ranking of those most responsible for unnecessary spending, provides a vital resource for stakeholders aiming to refine Medicare’s coverage policies. This detailed catalog is publicly accessible and can inform healthcare providers, insurers, and policymakers alike. For stakeholders concerned about the future viability of Medicare funding, such ledgers offer evidence-based guidance for systematic intervention.

Financially, these findings could steer transformative changes to Medicare spending patterns, potentially unlocking billions in savings that could be reinvested into high-value care areas. As the Medicare population continues to grow and age, optimizing resource allocation is an imperative not only for fiscal stewardship but also for enhancing healthcare outcomes. The study’s authors call on policymakers and healthcare systems to harness clinical evidence as the foundation of value-based insurance policy to realize these gains.

Importantly, the study was funded by Arnold Ventures, a philanthropic organization committed to advancing evidence-based policy, though it maintained no influence over the research. This independence enhances confidence in the objectivity and rigor of the findings. Dr. Kim’s background in biostatistics further attests to the strong analytical underpinnings of the study.

As the healthcare community confronts rising costs and an aging population, this study serves as a clarion call to reevaluate entrenched practices that may do more harm than good. Embracing clinically guided, patient-centered strategies for reducing low-value care could not only preserve vital Medicare funds but also protect patients from unnecessary interventions. This represents a pivotal opportunity to realign healthcare delivery with true value, efficiency, and patient well-being.

Subject of Research: People
Article Title: Projected Savings from Reducing Low-Value Services in Medicare
News Publication Date: 1-Aug-2025
Web References:

• https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.3050?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=080125
• https://www.uspreventiveservicestaskforce.org/uspstf/
• https://vbidcenter.org/initiatives/vbid-in-the-aca/
  References: Projected Savings from Reducing Low-Value Services in Medicare, JAMA Health Forum, doi:10.1001/jamahealthforum.2025.3050
  Keywords: Health insurance, Economics, Medical economics, Health care costs, Older adults, Preventive medicine, Medical tests, Medical diagnosis

Medicaid, the United States’ primary public health insurance program for low-income individuals and families, has historically limited postpartum coverage primarily to the first 60 days after childbirth. This restriction often leaves many new mothers without insurance precisely when they face the highest risk of complications ranging from chronic medical conditions to maternal mental health disorders. By extending coverage to a full year, the study suggests that many barriers to accessing necessary medical interventions and behavioral health services are mitigated, potentially transforming the postpartum care landscape.

The study utilized a comprehensive cohort analysis comparing health care utilization and outcomes among postpartum women before and after the implementation of extended Medicaid coverage. Through stratified data collection methods that captured prenatal, perinatal, and extensive postpartum medical claims, researchers were able to quantify increases in both preventive service usage and ongoing treatment for chronic conditions. This approach allowed a multifaceted assessment of how health coverage duration influences health trajectories beyond the immediate postpartum window.

One of the most striking revelations centers around the increased opportunities for behavioral health interventions, including screenings and treatment for postpartum depression, anxiety, and other psychiatric conditions. Behavioral health care is critical during postpartum phases, yet often remains underutilized due to insurance lapses. With extended Medicaid benefits, new mothers gained sustained access to counseling, therapy, and pharmacological treatments, thus addressing a significant public health gap with potential long-term benefits for both maternal and child well-being.

Chronic disease management, often sidelined during pregnancy, resumes priority once medial insurance stabilizes postpartum. The study highlights improved continuity of care for persistent conditions such as hypertension, diabetes, and cardiovascular disease—all of which significantly elevate maternal morbidity and mortality risks when unmanaged. Prolonged Medicaid coverage empowers healthcare providers to initiate, monitor, and adjust treatments that might otherwise be interrupted by insurance expiration, reducing adverse health events and emergency care reliance.

Prevention also features prominently as a benefit of extended coverage. Postpartum preventive care visits, screenings for infectious diseases, family planning services, and health education become more accessible when coverage extends beyond the initial postpartum period. These preventive measures contribute not only to healthier mothers but also create ripple effects for infant and household health environments. Consistent care coverage reduces the health disparities commonly observed in socioeconomically disadvantaged populations dependent on Medicaid.

From a health economics perspective, the extension of Medicaid postpartum coverage may be cost-effective in the long-term. By preventing costly emergency interventions and hospital readmissions linked to untreated postpartum complications, this policy shift potentially reduces overall healthcare expenditures. Improved management of behavioral and chronic health issues also decreases indirect societal costs related to lost productivity and psychological stress, underscoring the multifaceted benefits of such policy reforms.

This study carries substantial implications for public health policy, particularly as more states consider or have already implemented mandated 12-month postpartum Medicaid coverage under provisions such as the American Rescue Plan Act. By providing empirical data that correlate extended coverage with better healthcare access and outcomes, the research supports the case for universal adoption. Policymakers may find these insights invaluable for refining Medicaid regulations to prioritize the health and equity of postpartum populations.

The documented health benefits associated with extended Medicaid coverage also stress the importance of integrating behavioral and medical care services. The findings call for enhanced coordination between primary care providers, obstetricians, mental health specialists, and community health programs to holistically address postpartum needs. Such interprofessional collaboration could maximize coverage advantages, reduce fragmentation of care, and foster sustainable health improvements.

Moreover, the study underscores that social determinants of health, including socioeconomic status, housing stability, and access to transportation, intersect with insurance coverage to influence postpartum health outcomes. By ensuring continuous Medicaid coverage, healthcare systems can better connect patients with vital social support services that mitigate these broader determinants, thus promoting health equity and resilience among new mothers.

Given the profound maternal health disparities in the United States, particularly among women of color who face disproportionately high rates of maternal mortality and morbidity, the timing and nature of health coverage are pivotal. Extending Medicaid postpartum coverage emerges as a tangible policy lever to bridge these inequities by removing insurance churn as a barrier to consistent care, fostering culturally competent care models, and promoting sustained health engagement.

As this study contributes to the growing evidence base, it may also spur further research into specific mechanisms through which extended coverage impacts various medical and psychosocial outcomes. Future investigations could explore granular aspects such as medication adherence, infant health correlations, or long-term economic analysis, all of which would deepen understanding of the complexities inherent in postpartum healthcare delivery within Medicaid populations.

Ultimately, this study shines a spotlight on an urgent public health challenge: optimizing care for new mothers during the extended postpartum period. By revealing the benefits of a 12-month Medicaid coverage extension, it makes a powerful case for policy adjustments designed to support better health trajectories not only for postpartum women themselves but also for families and broader communities dependent on equitable healthcare access. The research invites both action and innovation in maternal health policy.

Subject of Research: Impact of extended Medicaid coverage on postpartum healthcare access and outcomes

Article Title: (doi:10.1001/jamahealthforum.2025.1630)

News Publication Date: Not specified

Web References: Not provided

Keywords: Birth rates, Parenting, Health insurance, Finance, Health care, Behaviorism, Medical treatments, Preventive medicine, Public health, Adverse effects